http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009125987-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24430c627c7e011dc7560cb085ee51b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e23a4c9cd982ccdb6082585045b94b7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ff4b03842b0118998a09c79e617caa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e559743173473475142b7bd8a978298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3aeb5e606c1fb1a2ff49eb8ab418b01a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59f7f9ddaba3fc135286492149225a27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f0666ada7b158089d3a4fa378fb0aa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80e7573d60d56d2d64d48cfdcd3b8052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c33460821110221bacdadf125aab6895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28627059e1e1bdd2890ef9b952b82b8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1eed52535c1bed81a707da41038a3c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4044730fef17b5321f3fb5565480881a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e72d950c05a0d97afa569ed9f14dd91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37d9ba45ce94b1b616e1d3b5bf7d36c8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4607569d4b1e38367794c3271e79551a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f62eb3dbca5b753e7ee9dc60e247e814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_241eef4c43bf4672b2074bfc09ff0d2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_574482d6387d9e0f545c20d4dfedb588
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_183dade5dfa077a2761dcfb432594837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede000e2a8311c51f7dad5644bcd98df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c699517916d2d576c1c38c39853e6595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d9a9e68aef96ac7f97bc89eb5a94945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_436255d137daf3dcd7fa5b2af3cb2395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8446473ac55b5cd0c33730349cb5c053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9e0ee5a0ba559e9b41fe5e87a9bd15c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc79c817ed0d9917fb213ae9ee3a0788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe45bfc38ff2a1185736430d2c769f78
publicationDate 2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009125987-A3
titleOfInvention Pharmaceutical formulation
abstract The present invention relates to a pharmaceutical formulation containing an extended-release compartment having a dihydropyridine calcium channel blocker and an immediate-release compartment having an angiotensin-2 receptor blocker. The present invention provides the pharmaceutical formulation in which the dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker are separately contained in each compartment and of which release is controlled. Since each different drug contained in each different compartment of the formulation is released at a different time, the pharmaceutical formulation of the present invention minimizes the antagonism and side effects between drugs and maximizes the specific effect of the drugs. The pharmaceutical formulation by the specific combination between the two drugs according to the present invention has remarkably good effects in treating or preventing diseases compared with the single administration of each of the drugs or the simple combined administration of the drugs.
priorityDate 2008-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080016801-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070078625-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010022385-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128776154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66586608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66586609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13347754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424269

Total number of triples: 52.